Complete Pathological Response to Neoadjuvant Treatment in Pancreatic Ductal Adenocarcinoma—Can We Achieve a Long-Term Survival? A Narrative Review

Magdalena Gajda, Ewa Grudzińska, Łukasz Liszka, Joanna Pilch-Kowalczyk, Sławomir Mrowiec, Barbara Illi, Francesco Leonardi, Ingrid Garajova · 2025

Read Complete Pathological Response to Neoadjuvant Treatment in Pancreatic Ductal Adenocarcinoma—Can We Achieve a Long-Term Survival? A Narrative Review by Magdalena Gajda, Ewa Grudzińska, Łukasz Liszka, Joanna Pilch-Kowalczyk, Sławomir Mrowiec, Barbara Illi, Francesco Leonardi, Ingrid Garajova (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12734195.txt.

Description

Magdalena Gajda and co-authors review, in a 2025 paper, a rare best-case outcome in pancreatic cancer care. This cancer kills more Europeans than almost any other, and only about one patient in ten lives five years. Surgery is the only cure, and for borderline cases doctors first shrink the tumor with other treatment. Rarely, the removed tissue then shows no living tumor at all, a complete pathological response.

The review asks whether patients who reach that state live longer, and why so few do. The answer so far is hopeful: a complete response seems tied to a much better outlook. What sets those patients apart is unknown, though. The authors call for studies on large groups to find the factors that raise the chance.

Catalog record

CREATORMagdalena Gajda, Ewa Grudzińska, Łukasz Liszka, Joanna Pilch-Kowalczyk, Sławomir Mrowiec, Barbara Illi, Francesco Leonardi, Ingrid Garajova
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE35 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12734195

Browse the full library · About the Tower of Babel